- Global Gases and Engineering Company Turns to Thomson Reuters for Comprehensive Regulatory Solution
—
PHILADELPHIA and LONDON, June 15PHILADELPHIA and LONDON, June 15 /PRNewswire/ -- The Healthcare & Science business of Thomson Reuters today announced Linde Healthcare has purchased Liquent Regulatory Software -- a solution specifically designed to meet the regulatory needs of life sciences organizations. Linde Healthcare is a global business unit of The Linde Group, a world-leading gases and engineering company.
Through its purchase of both Liquent InSight(R) Manager and Liquent InSight(R) Publisher, Linde Healthcare has compiled a robust software solution that provides a centralized, global view of product details, documents, and submissions to support collaboration, compliance requirements and the eCTD.
"As a global company, operating in more than 100 countries, gaining access to an integrated solution is critical. Utilizing both Liquent InSight Manager and Liquent InSight Publisher allows us to have a complete view of the regulatory process," said Ann-Cathrin Jareman, Head of Regulatory Affairs at Linde Healthcare. "Liquent InSight Manager is essential for our regulatory planning and product management, and works seamlessly with Liquent InSight Publisher, which will enable us to quickly and easily create regulatory dossiers."
Liquent Regulatory Software will aid Linde Healthcare navigate the CTD and eCTD submission processes. The solution offers customers a centralized view of all the moving parts, including product details, change control, documents, tracking and submissions to support change control, tracking and compliance requirements for multiple submission formats.
"We are pleased to grow our long-term relationship with Linde Healthcare, a truly world-class company," said Jeff Huntsman, vice president, global sales, Services and Software Solutions at Thomson Reuters. "We are confident that the Liquent InSight Platform will provide its employees with the most efficient, integrated solution."
The Linde Group
The Linde Group is a world leading gases and engineering company with almost 52,000 employees working in more than 100 countries worldwide. In the 2008 financial year it achieved sales of EUR 12.7 billion. The strategy of The Linde Group is geared toward sustainable earnings-based growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. Linde is committed to technologies and products that unite the goals of customer value and sustainable development. For more information, see The Linde Group online at http://www.linde.com
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.
Note to editors: Visit with experts from Thomson Reuters at DIA Annual Conference in San Diego, June 22-24, 2009 at Booth #821.
© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
